Company Filing History:
16 out of 3,684 
1 out of 832,843 Years Active: 1998-2015
Title: Dalton King: Innovator in Central Nervous System Treatments
Introduction
Dalton King is a prominent inventor based in Hamden, CT (US), known for his significant contributions to the field of pharmacology. With a total of 17 patents to his name, he has made remarkable strides in developing compounds that target the NR2B receptor, which plays a crucial role in various central nervous system disorders.
Latest Patents
Among his latest patents are selective NR2B antagonists. These patents disclose compounds of formula I, including their salts, as well as compositions and methods for using these compounds. The compounds serve as ligands of the NR2B receptor and hold potential for treating various disorders of the central nervous system. The innovative nature of these compounds positions them as valuable assets in the pharmaceutical industry.
Career Highlights
Dalton King has had a distinguished career, working with notable companies such as Bristol-Myers Squibb Company. His work in these organizations has allowed him to develop and refine his inventions, contributing to advancements in medical treatments.
Collaborations
Throughout his career, Dalton has collaborated with esteemed colleagues, including John E. Macor and Richard Eric Olson. These partnerships have fostered an environment of innovation and have led to the successful development of his patented compounds.
Conclusion
Dalton King's work exemplifies the impact of innovation in the field of medicine, particularly in the treatment of central nervous system disorders. His contributions through patents and collaborations continue to influence the pharmaceutical landscape.